Skip to product information
1 of 1

Pfizer

Neuraben 100mg 30 capsules

Neuraben 100mg 30 capsules

Regular price €15,20
Regular price €16,00 Sale price €15,20
Sale Sold out
Taxes included. Shipping calculated at checkout.
Logo Farmaci da banco

NET WEIGHT OF THE PRODUCT

30ct

EAN

023585019

MINSAN

023585019

View full details

In ottemperanza all'articolo 118 “autorizzazione della pubblicità presso il pubblico” del decreto legislativo 24 aprile 2006, numero 219

INDICATIONS

Polyneuritis due to Vitamin B1, B6 and B12 deficiency states.

 

ACTIVE INGREDIENTS

Each hard capsule contains: Active ingredients: Benzoyloxymethylthiamine 100 mg Pyridoxine hydrochloride 150 mg Cyanocobalamin 500 mcg Excipient with known effects: Sunset yellow . For the full list of excipients, see section 6.1.

 

EXCIPIENTS

Talc, magnesium stearate, polyethylene glycol 6000. Each cap contains: Head: Titanium dioxide (E171), sunset yellow (E110), gelatin. Body: Titanium dioxide (E171), sunset yellow (E110), gelatin.

 

CONTRAINDICATIONS AND SIDE EFFECTS

Hypersensitivity to the active substances or to any of the excipients listed in paragraph 6.1.

 

DOSAGE

Usually 1 capsule 3 times a day.

 

CONSERVATION

This medicinal product does not require any special storage conditions.

 

WARNINGS

Caution is recommended when administering to subjects undergoing treatment with levodopa because pyridoxine can antagonize its therapeutic effects. Keep out of reach of children. Neuraben contains sunset yellow (E110) which may cause allergic reactions.

 

INTERACTIONS

Vitamin B6 can antagonize the therapeutic effects of levodopa.

 

SIDE EFFECTS

Neuraben is generally well tolerated and no toxic and accumulation effects are known. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it/it/responsabili.

 

OVERDOSE

There are no known symptoms of overdose.

 

PREGNANCY AND BREASTFEEDING

There are no contraindications to the use of NEURABEN in these conditions.

 

EFFECTS ON DRIVING ABILITY

Neuraben has no or negligible influence on the ability to drive or use machines.

1 of 4

Content Responsibility This sheet contains information that is not intended to replace a diagnosis or medical advice, as only the doctor can draw up any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first. Please note The names of the products, the ingredients and the percentages indicated in the descriptions are purely indicative, they may be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting in real time to such updates, the photos and technical information of the products inserted on Dottortili.com may differ from those reported on the label or otherwise disseminated by the manufacturing companies. The only identification element is the MINSAN ministerial code. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines all responsibility for any errors, omissions or failure to update the same. Dottortili.com does not assume responsibility for damages of any nature that may arise from access to the information published. Data source: Farmadati Italia Website: www.farmadati.it The Farmadati Italia Database is used by almost all pharmacies, parapharmacies, herbalist shops, health shops, large-scale retail trade, computerized doctors, etc. thanks to the company's historical guarantee of reliability, seriousness and professionalism on the national territory. The Farmadati Italia Srl management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO/IEC 27001:2017 for information security management systems.